DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,307,000 | -70.9% | 709,674 | -46.2% | 0.06% | -69.2% |
| Q2 2021 | $49,189,000 | +41.8% | 1,318,047 | -2.1% | 0.21% | +37.0% |
| Q1 2021 | $34,683,000 | +2.9% | 1,346,426 | -12.0% | 0.15% | -18.9% |
| Q4 2020 | $33,720,000 | +12.2% | 1,530,652 | -6.3% | 0.19% | +22.6% |
| Q3 2020 | $30,041,000 | -24.4% | 1,633,600 | +1.6% | 0.16% | -31.4% |
| Q2 2020 | $39,748,000 | +24.2% | 1,607,930 | -7.7% | 0.23% | +13.6% |
| Q1 2020 | $32,007,000 | -17.3% | 1,742,360 | -0.8% | 0.20% | +7.0% |
| Q4 2019 | $38,680,000 | +52.6% | 1,755,812 | -0.5% | 0.19% | +42.0% |
| Q3 2019 | $25,347,000 | – | 1,765,156 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |